Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055791) titled 'A Multicenter Crossover Comparative Study of Appropriate Dosing Dates for Tilzepatide' on April 1.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Active
Primary Sponsor:
Institute - University of Miyazaki
Condition:
Condition - type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study was to elucidate the appropriate day of the week for administering tilzepatide, a drug used to treat diabetes mellitus. The day of the week with the highest ca...